Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Hematologic Malignancies
Immunotherapy
Questions discussed in this category
How do you approach evaluation and management of arthralgia in a patient after CAR-T cell therapy?
1 Answer available
Is there a role for IL2-receptor antagonists and TNF-alpha inhibitors in cytokine release syndrome as a complication of CAR-T or immunotherapy?
1 Answer available
How early have you been able to detect a response with CAR-T in patients with relapsed DLBCL?
3 Answers available
17739
13957
3585
Papers discussed in this category
The New England journal of medicine, 2017-12-28
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
Exp Hematol Oncol, 2021 Feb 19
Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy.
Related Topics in Hematologic Malignancies
Breast Cancer
Head and Neck Cancers
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers
Pediatric Oncology
Sarcoma